Lenvatinib mesylate
Lenvatinib mesylate (E7080 mesylate), an oral, multi-targeted tyrosine kinase inhibitor that inhibits VEGFR1-3, FGFR1-4, PDGFR, KIT, and RET, shows potent antitumor activities.
Product Specifications
CAS Number
857890-39-2
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
522.96
Molecular Formula
C₂₂H₂₃ClN₄O₇S
Notes
Research use only, not for human use.
Receptor
——
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS1322071-01 0.02 mg (E-Coli)
Recombinant Pseudomonas syringae pv. tomato HTH-type transcriptional regulator BetI (betI)
Sign In for Pricing
View Details MBS1322071-02 0.1 mg (E-Coli)
Recombinant Pseudomonas syringae pv. tomato HTH-type transcriptional regulator BetI (betI)
Sign In for Pricing
View Details 
MBS1322071-03 0.02 mg (Yeast)
Recombinant Pseudomonas syringae pv. tomato HTH-type transcriptional regulator BetI (betI)
Sign In for Pricing
View Details MBS1322071-04 0.1 mg (Yeast)
Recombinant Pseudomonas syringae pv. tomato HTH-type transcriptional regulator BetI (betI)
Sign In for Pricing
View Details